{
    "xml": "<topic id=\"PHP18798\" outputclass=\"drug\" rev=\"1.17\" type=\"drug\" namespace=\"/drugs/ceftaroline-fosamil\" basename=\"ceftaroline-fosamil\" title=\"CEFTAROLINE FOSAMIL\">\n<title>CEFTAROLINE FOSAMIL</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_1234\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/cephalosporins/ceftaroline\">Ceftaroline</xref>\n</p>\n<data name=\"vtmid\">21387311000001104</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_341352686\" title=\"Cephalosporins\">Cephalosporins</xref>\n</data>\n<data name=\"inheritsFromClass\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34534\" title=\"CEPHALOSPORINS\" namespace=\"/drug-classes/cephalosporins\">CEPHALOSPORINS</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP70356\" outputclass=\"indicationsAndDose\" rev=\"1.13\" parent=\"/drugs/ceftaroline-fosamil\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Community-acquired pneumonia</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>600&#8239;mg every 12&#8239;hours for 5&#8211;7 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Complicated skin and soft-tissue infections</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By intravenous infusion</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>600&#8239;mg every 12&#8239;hours for 5&#8211;14 days.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70552\" outputclass=\"cautions\" rev=\"1.9\" parent=\"/drugs/ceftaroline-fosamil\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Seizure disorders</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70322\" outputclass=\"pregnancy\" parent=\"/drugs/ceftaroline-fosamil\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid unless essential&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70566\" outputclass=\"breastFeeding\" parent=\"/drugs/ceftaroline-fosamil\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70293\" outputclass=\"renalImpairment\" parent=\"/drugs/ceftaroline-fosamil\">\n<title>Renal impairment</title>\n<body>\n<section outputclass=\"doseAdjustments\">\n<sectiondiv>\n<p>400&#8239;mg every 12 hours if eGFR 30&#8211;50&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70610\" outputclass=\"directionsForAdministration\" rev=\"1.22\" parent=\"/drugs/ceftaroline-fosamil\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>For <i>intravenous infusion</i>, give intermittently <i>in</i> Glucose 5% <i>or</i> Sodium chloride 0.9%. Reconstitute 600&#8239;mg with 20&#8239;mL water for injections, then dilute with 250&#8239;mL infusion fluid (in fluid restriction, may be diluted with 50&#8211;100&#8239;mL infusion fluid); give over 60 minutes.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP70250\" outputclass=\"nationalFunding\" rev=\"1.13\" parent=\"/drugs/ceftaroline-fosamil\">\n<title>National funding/access decisions</title>\n<body>\n<section>\n<sectiondiv outputclass=\"smcDecisions\">\n<p outputclass=\"title\">Scottish Medicines Consortium (SMC) Decisions</p>\n<sectiondiv outputclass=\"smcDecision\">\n<sectiondiv>\n<p>The <i>Scottish Medicines Consortium</i>, has advised (Dec 2012) that ceftaroline fosamil (<i>Zinforo</i>\n<tm tmtype=\"reg\"/>) is accepted for restricted use within NHS Scotland when meticillin&#8211;resistant <ph outputclass=\"organism\">\n<i>S. aureus</i>\n</ph> is suspected in complicated skin and soft-tissue infection and vancomycin cannot be used.</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP18798-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/ceftaroline-fosamil\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76153\" title=\"Powder for solution for infusion\" namespace=\"/drugs/ceftaroline-fosamil/powder-for-solution-for-infusion\">Powder for solution for infusion</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78145\" namespace=\"/treatment-summaries/cephalosporins\" title=\"Cephalosporins\" count=\"4\" rel=\"backlink\">Cephalosporins</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_1234\" namespace=\"/interactions/list-of-drug-interactions/antibacterials/cephalosporins/ceftaroline\" title=\"Ceftaroline\" count=\"1\" rel=\"link\">Ceftaroline</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drugClass\" href=\"#PHP34534\" namespace=\"/drug-classes/cephalosporins\" title=\"CEPHALOSPORINS\" count=\"1\" rel=\"link\">CEPHALOSPORINS</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76153\" namespace=\"/drugs/ceftaroline-fosamil/powder-for-solution-for-infusion\" title=\"Powder for solution for infusion\" count=\"1\" rel=\"link\">Powder for solution for infusion</xref>\n</links>\n</topic>",
    "id": "PHP18798",
    "outputclass": "drug",
    "rev": "1.17",
    "type": "drug",
    "namespace": "/drugs/ceftaroline-fosamil",
    "basename": "ceftaroline-fosamil",
    "title": "CEFTAROLINE FOSAMIL",
    "interactants": [
        {
            "id": "bnf_int_1234",
            "label": "Ceftaroline"
        }
    ],
    "vtmid": "21387311000001104",
    "drugClassification": [
        "Cephalosporins"
    ],
    "inheritsFromClass": [
        "CEPHALOSPORINS"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Community-acquired pneumonia",
                        "html": "Community-acquired pneumonia"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "600 mg every 12 hours for 5&#8211;7 days.",
                        "html": "<p>600&#8239;mg every 12&#8239;hours for 5&#8211;7 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Complicated skin and soft-tissue infections",
                        "html": "Complicated skin and soft-tissue infections"
                    }
                ],
                "specificity": {
                    "routes": [
                        "intravenous infusion"
                    ],
                    "textContent": "By intravenous infusion",
                    "html": "By intravenous infusion"
                },
                "adult": [
                    {
                        "textContent": "600 mg every 12 hours for 5&#8211;14 days.",
                        "html": "<p>600&#8239;mg every 12&#8239;hours for 5&#8211;14 days.</p>"
                    }
                ]
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Seizure disorders",
                "html": "Seizure disorders"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid unless essential&#8212;no information available.",
                "html": "<p>Manufacturer advises avoid unless essential&#8212;no information available.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid&#8212;no information available.",
                "html": "<p>Manufacturer advises avoid&#8212;no information available.</p>"
            }
        ]
    },
    "renalImpairment": {
        "doseAdjustments": [
            {
                "type": "doseAdjustments",
                "textContent": "400 mg every 12 hours if eGFR 30&#8211;50 mL/minute/1.73 m2.",
                "html": "<p>400&#8239;mg every 12 hours if eGFR 30&#8211;50&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            }
        ],
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid if eGFR less than 30 mL/minute/1.73 m2.",
                "html": "<p>Manufacturer advises avoid if eGFR less than 30&#8239;mL/minute/1.73&#8239;m<sup>2</sup>.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "For intravenous infusion, give intermittently in Glucose 5% or Sodium chloride 0.9%. Reconstitute 600 mg with 20 mL water for injections, then dilute with 250 mL infusion fluid (in fluid restriction, may be diluted with 50&#8211;100 mL infusion fluid); give over 60 minutes.",
                "html": "<p>For <i>intravenous infusion</i>, give intermittently <i>in</i> Glucose 5% <i>or</i> Sodium chloride 0.9%. Reconstitute 600&#8239;mg with 20&#8239;mL water for injections, then dilute with 250&#8239;mL infusion fluid (in fluid restriction, may be diluted with 50&#8211;100&#8239;mL infusion fluid); give over 60 minutes.</p>"
            }
        ]
    },
    "nationalFunding": {
        "smcDecisions": [
            {
                "type": "smcDecisions",
                "textContent": "The Scottish Medicines Consortium, has advised (Dec 2012) that ceftaroline fosamil (Zinforo ) is accepted for restricted use within NHS Scotland when meticillin&#8211;resistant S. aureus is suspected in complicated skin and soft-tissue infection and vancomycin cannot be used.",
                "html": "<p>The <i>Scottish Medicines Consortium</i>, has advised (Dec 2012) that ceftaroline fosamil (<i>Zinforo</i> <tm tmtype=\"reg\"/>) is accepted for restricted use within NHS Scotland when meticillin&#8211;resistant <ph outputclass=\"organism\"> <i>S. aureus</i> </ph> is suspected in complicated skin and soft-tissue infection and vancomycin cannot be used.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76153",
                "label": "Powder for solution for infusion",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78145",
                "label": "Cephalosporins",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_1234",
                "label": "Ceftaroline",
                "type": "interaction"
            }
        ],
        "drugClass": [
            {
                "id": "PHP34534",
                "label": "CEPHALOSPORINS",
                "type": "drugClass"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76153",
                "label": "Powder for solution for infusion",
                "type": "medicinalForm"
            }
        ]
    }
}